Board considers Final Dividend for the FY 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals Ltd's Board of Directors, at its meeting held on May 28, 2025, recommended a final dividend of Rs. 0.80 per equity share (8% on the paid-up share capital) for the financial year ended March 31, 2025. The dividend is subject to approval from shareholders at the upcoming Annual General Meeting (AGM). The company has not yet announced the record date, AGM date, or the dividend payment date, and will communicate these in due course. The equity shares have a face value of Rs. 10 each.
Shareholders as on the record date (to be announced) will be eligible to receive the Rs. 0.80 per share dividend, providing a modest income. The recommendation signals stable profitability and a shareholder-friendly approach, though the actual yield depends on the stock's prevailing market price.